Dishman Sept qtr PAT seen up 21% at Rs 10cr: Dolat Capital

Published on Tue, Oct 11, 2011 at 11:46 |  Source : Moneycontrol.com

Updated at Tue, Oct 11, 2011 at 13:04  

5238 Investors following Dishman Pharma. Share this News with them.
0
0
Share on Tumblr
Dishman Sept qtr PAT seen up 21% at Rs 10cr: Dolat Capital

ALSO READ

Dolat Capital has come out with its earning estimates on Pharma sector for the quarter ended September 2011. According to the research firm, Dishman September quarter net sales are expected to go up by 15.1% at Rs 245 crore, year-on-year, (YoY) basis.

The company's net profit is expected to go up 20.9% at Rs 10.3 cr crore on YoY basis.

  

Trending News

Business News

Recharge your Tata Docomo prepaid card by tweeting at them
IT dept freezes Kingfisher Airlines' bank a/c, again "IT dept freezes Kingfisher Airlines' bank a/c, again"

Mamata, Shah Rukh party; KKR players left out

RBI Governor Need Coordinated Debt Mgmt To Avoid Liquidity Pressure

The latest earning numbers FIRST on CNBC-TV18
Videos

May 29 2012, 12:19

Expect Tata Motors Q4 PAT at Rs 4200 cr: StanChart

- in Brokerage Results Estimates

Interviews

May 29 2012, 17:34 | Source: CNBC-TV18

Will raise Rs 250cr via ECB route next year: Hind Copper  

May 29 2012, 15:44 | Source: CNBC-TV18

Improving priority sector lending norms main focus: IDBI  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!